Inhibikase Therapeutics Inc (IKT)
EBITDA Growth
-75.45%
Quarterly · Period ending:
IKT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-75.45%period ending
Latest reported-75.45%period ending
IKT Quarterly EBITDA YoY % (-2435.42% → -75.45%)
Year-over-year change
High-resolution chart · PNG
IKT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -75.4458% | |
| -4.0039% | |
| -8.3081% | |
| -129.3601% | |
| -125.4483% | |
| -239.2201% | |
| -190.696% | |
| -25.7786% | |
| 11.8482% | |
| -3.8082% | |
| 2.4016% | |
| -2.1308% | |
| 100% | |
| -2,435.4207% |